I+D de fármacos
GI-1606
![Foto de I+D de fármacos](/img/grupo.png)
![Foto de Baqiyatallah University of Medical Sciences](/img/noimage_org.png)
Baqiyatallah University of Medical Sciences
Teherán, IránPublicacións en colaboración con investigadores/as de Baqiyatallah University of Medical Sciences (8)
2019
-
Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future
Current medicinal chemistry, Vol. 26, Núm. 18, pp. 3253-3259
-
Hesperidin as a neuroprotective agent: A review of animal and clinical evidence
Molecules, Vol. 24, Núm. 3
2018
-
Nanomedicine and Parkinson’s disease: A nanoparticle medical approach
Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 153-168
2017
-
A medical approach to the monoamine oxidase inhibition by using 7H-benzo[e]perimidin-7-one derivatives
Current Topics in Medicinal Chemistry, Vol. 17, Núm. 7
-
Aporphine alkaloids and their antioxidant medical application: From antineoplastic agents to motor dysfunction diseases
Current Organic Chemistry, Vol. 21, Núm. 4, pp. 342-347
2016
-
Aporphines and parkinson’s disease: Medical tools for the future
Current Topics in Medicinal Chemistry, Vol. 16, Núm. 17, pp. 1906-1909
2015
-
Anxiolytic-like effects of 7H-benzo[e]perimidin-7-one derivatives through elevated plus-maze test in mice
Current Topics in Medicinal Chemistry, Vol. 15, Núm. 17, pp. 1750-1754
-
Nanoparticles in the treatment of mental disorders: A new tool in the psychiatric medication
Current Topics in Medicinal Chemistry, Vol. 15, Núm. 4, pp. 282-286